REGULATION OF HUMAN ALVEOLAR MACROPHAGE INFLAMMATORY CYTOKINES BY TYLOXAPOL - A COMPONENT OF THE SYNTHETIC SURFACTANT EXOSURF

被引:23
作者
THOMASSEN, MJ [1 ]
ANTAL, JM [1 ]
DIVIS, LT [1 ]
WIEDEMANN, HP [1 ]
机构
[1] CLEVELAND CLIN FDN,DEPT IMMUNOL,CLEVELAND,OH 44195
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1995年 / 77卷 / 02期
关键词
D O I
10.1006/clin.1995.1144
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously demonstrated that the synthetic surfactant Exosurf and a modified natural surfactant, Survanta, both down-regulated endotoxin-stimulated production of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6) in human alveolar macrophages. To further characterize the source of the inhibitory effect of surfactant, the three individual components of Exosurf were evaluated. Dipalmitoylphosphatidylcholine had no effect on endotoxin-stimulated cytokine secretion. Cetyl alcohol (spreading agent) compromised macrophage function as measured by adherence. However, at concentrations equivalent to those found in the complete surfactant (Exosurf) preparation, tyloxapol (nonionic dispersing agent) was inhibitory in a dose-dependent manner. The viability of alveolar macrophages as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheny tetrazolium bromide cleavage assay was not affected by incubation in Exosurf or any of its individual components. Cytokine secretion and mRNA levels of endotoxin-stimulated alveolar macrophages were decreased by tyloxapol. These data suggest that tyloxapol alone, like Exosurf, has an inhibitory effect on cytokine production which may be pretranslationally mediated. (C) 1995 Academic Press, Inc.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 33 条
[1]   FUNCTION AMD ACTIVATION OF NF-KAPPA-B IN THE IMMUNE-SYSTEM [J].
BAEUERLE, PA ;
HENKEL, T .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :141-179
[2]  
EIERMAN DF, 1989, J IMMUNOL, V142, P1970
[3]  
ENHOUNG G, 1992, UPDATE PULMONARY DIS, P213
[4]  
GEERTSMA MF, 1993, J IMMUNOL, V150, P2391
[5]  
GEERTSMA MF, 1994, IMMUNOLOGY, V82, P450
[6]   SYNTHETIC SURFACTANT SCAVENGES OXIDANTS AND PROTECTS AGAINST HYPEROXIC LUNG INJURY [J].
GHIO, AJ ;
FRACICA, PJ ;
YOUNG, SL ;
PIANTADOSI, CA .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 77 (03) :1217-1223
[7]   SURFACTANT CHEMICAL-COMPOSITION AND BIOPHYSICAL ACTIVITY IN ACUTE RESPIRATORY-DISTRESS SYNDROME [J].
GREGORY, TJ ;
LONGMORE, WJ ;
MOXLEY, MA ;
WHITSETT, JA ;
REED, CR ;
FOWLER, AA ;
HUDSON, LD ;
MAUNDER, RJ ;
CRIM, C ;
HYERS, TM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1976-1981
[8]   EVIDENCE OF LUNG SURFACTANT ABNORMALITY IN RESPIRATORY-FAILURE - STUDY OF BRONCHOALVEOLAR LAVAGE PHOSPHOLIPIDS, SURFACE-ACTIVITY, PHOSPHOLIPASE-ACTIVITY, AND PLASMA MYOINOSITOL [J].
HALLMAN, M ;
SPRAGG, R ;
HARRELL, JH ;
MOSER, KM ;
GLUCK, L .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) :673-683
[9]   TUMOR-NECROSIS-FACTOR LEVELS IN SERUM AND BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
HYERS, TM ;
TRICOMI, SM ;
DETTENMEIER, PA ;
FOWLER, AA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02) :268-271
[10]   ELEVATED INTERLEUKIN-1 RELEASE BY HUMAN ALVEOLAR MACROPHAGES DURING THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
JACOBS, RF ;
TABOR, DR ;
BURKS, AW ;
CAMPBELL, GD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (06) :1686-1692